Related Experiment Video
Updated: Jun 20, 2026

A Multicenter MRI Protocol for the Evaluation and Quantification of Deep Vein Thrombosis
Published on: June 2, 2015
Contrast medium volume to estimated glomerular filtration rate ratio as a predictor of contrast-induced nephropathy
Tsuyoshi Nozue1, Ichiro Michishita, Taku Iwaki
1Division of Cardiology, Department of Internal Medicine, Yokohama Sakae Kyosai Hospital, Federation of National Public Service Personnel Mutual Associations, 132 Katsura-cho, Sakae-ku, Yokohama 247-8581, Japan. nozue2493@yahoo.co.jp
Insights
The contrast medium volume to estimated glomerular filtration rate (CMV/eGFR) ratio is a strong predictor of contrast-induced nephropathy (CIN) after percutaneous coronary intervention (PCI). This ratio can help identify patients at risk for CIN, improving patient outcomes.
Area of Science:
- Cardiology
- Nephrology
- Radiology
Background:
- Contrast-induced nephropathy (CIN) is a significant complication following coronary angiography and percutaneous coronary intervention (PCI).
- Identifying patients at risk for CIN is crucial for minimizing its incidence and associated adverse outcomes.
Purpose of the Study:
- To investigate clinical factors associated with CIN development in patients undergoing elective PCI.
- To identify a reliable predictor for CIN in this patient population.
Main Methods:
- Retrospective analysis of 60 stable angina patients who underwent elective PCI.
- Comparison of clinical factors, including baseline characteristics, procedural details, and contrast volume, between patients with and without CIN.
- Statistical analysis, including stepwise regression, to identify independent predictors of CIN.
Main Results:
- The incidence of CIN was 13%.
- Patients who developed CIN had significantly lower estimated glomerular filtration rates (eGFR) and received higher volumes of contrast medium.
- The contrast medium volume to eGFR ratio (CMV/eGFR) was significantly greater in the CIN group and identified as an independent predictor of CIN.
- A CMV/eGFR ratio cutoff of >5.1 demonstrated 87.5% sensitivity and 74.5% specificity for detecting CIN.
Conclusions:
- The CMV/eGFR ratio is a valuable and independent predictor of CIN following elective PCI.
- This ratio can aid in risk stratification and inform preventative strategies for CIN.
Background:
Contrast-induced nephropathy (CIN) has been recognized as a serious complication of diagnostic coronary angiography and percutaneous coronary intervention (PCI), and has been associated with prolonged hospitalization and adverse clinical outcomes. A key step to minimize the risk for developing CIN is to identify patients at risk for CIN.
Methods And Results:
We retrospectively investigated clinical factors associated with the development of CIN in 60 stable angina patients who had undergone elective PCI. The frequency of CIN was 13% (8/60). There were neither any significant differences in age, gender, baseline serum creatinine or hemoglobin levels, nor in the rate of diabetes mellitus between the CIN and the non-CIN group. However, the estimated glomerular filtration rate (eGFR) was significantly lower (40.4+/-11.4 mL/min/1.73 m(2) vs. 57.4+/-22.6 mL/min/1.73 m(2), p=0.044), and number of treated vessels (1.5+/-0.8 vs. 1.2+/-0.4, p=0.039) and stents used (2.1+/-0.6 vs. 1.4+/-0.6, p=0.007) were significantly higher in the CIN group. In addition, the amount of contrast medium was significantly larger (272+/-37 mL vs. 201+/-62 mL, p=0.003) and the contrast medium volume (CMV) to eGFR ratio (CMV/eGFR) was significantly greater (7.4+/-2.9 vs. 4.0+/-2.0, p=0.0001) in the CIN group. Stepwise regression analysis showed that the CMV/eGFR ratio was a significant independent predictor of CIN (p=0.035). At a cut-off point of >5.1, the CMV/eGFR ratio exhibited 87.5% sensitivity and 74.5% specificity for detecting CIN.
Conclusion:
The CMV/eGFR ratio could be a useful predictor of CIN developing after elective PCI.
Related Concept Videos
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration
Drug Dosing in Renal Diseases: Measurement of Glomerular Filtration Rate
Cardiac Catheterization I: Pre-Procedure Overview
Drug Dosing in Renal Diseases: Measurement of Serum Creatinine Concentration and Clearance
Imaging Studies III: Computed Tomography
Imaging Studies for Cardiovascular System V: CT